Design and build
The CurrentBody Series 2 departs from brittle polycarbonate shells by using a flexible liquid silicone mask designed to rest directly against the skin. Its matrix houses 236 embedded light-emitting diodes, configured to maintain consistent proximity to facial contours. Silicone construction offers practical advantages: it can be sanitized with simple alcohol wipes, tolerates mechanical flexing during travel, and distributes its weight across the face rather than concentrating pressure on the nasal bridge. The device relies on an included rechargeable lithium-ion battery, eliminating reliance on stationary mains power during use. An embedded NFC Veritace card is included to display individual unit manufacturing data via smartphone scanning. While the 3.11-pound shipping weight suggests substantial overall packaging, the mask itself remains pliable. The fit system aims to limit the optical dispersion common to rigid masks, ensuring the diodes maintain stable positioning across the forehead, cheeks, and jawline throughout treatment cycles.
Real-world performance
Phototherapy efficacy depends entirely on optical output: specific wavelengths, irradiance, and cumulative exposure duration. CurrentBody provides clear transparency regarding its spectrum, targeting 633nm red, 830nm near-infrared, and 1072nm deep near-infrared light. The integration of 1072nm represents a technical upgrade aimed at deeper tissue interaction compared to standard dual-wavelength arrays. However, the manufacturer data sheet omits published irradiance values, which are typically measured in milliwatts per square centimeter. Without this metric, along with unstated factory cycle durations, calculating the precise energy density in joules per square centimeter is impossible prior to purchase. The Veritace NFC card claims to supply individual unit performance verification, but core technical parameters should ideally be accessible before committing capital. Buyers should note that while diode distribution is generous across the 236 positions, actual photobiomodulation effects require consistent application under calibrated power outputs that CurrentBody should disclose openly.
Value for money
Priced at $469.99, the Series 2 sits in the premium tier of home phototherapy equipment. It carries a 4.1 out of 5 rating across more than 700 consumer reviews, reflecting generally positive user satisfaction. From a financial perspective, LED technology provides a clear structural advantage over modalities like radiofrequency or microcurrent: there are no mandatory conductive gels, serum cartridges, or replaceable head attachments. Once the initial hardware investment is made, total cost of ownership remains flat for the lifespan of the integrated lithium-ion battery. The primary trade-off rests in whether the addition of the 1072nm wavelength and the silicone refit justify a near-$470 outlay against entry-level flexible masks. For users committed to routine, long-term phototherapy, the absence of recurring supply fees helps offset the upfront cost, provided the hardware achieves an operational life of multiple years.
Who should skip it
Certain users should refrain from purchasing the CurrentBody Series 2. The manufacturer explicitly notes that contraindications must be evaluated before beginning therapy. Individuals taking photosensitizing medications, such as specific tetracyclines, isotretinoin, or particular topical retinoids, risk phototoxic reactions and should not use high-density LED arrays. Those diagnosed with light-triggered migraines, epilepsy, or active facial lesions must also pass. Furthermore, individuals dealing with melasma should exercise caution: although red light is generally non-thermal, deep near-infrared emissions at 1072nm can produce subtle localized heat that may stimulate hyperpigmentation in melasma-prone skin types. Finally, prospective purchasers who demand independently audited clinical trials, verified FDA 510(k) clearance paperwork, or explicit out-of-the-box irradiance data before buying should look to brands that publish their full laboratory radiometric test reports directly on their public retail listings.
